Certain chemical compounds can disable the bacterial immune systems that protect them from viruses, making the bacteria ...

Nearly three months after winning a contentious bid to buy obesity drugmaker Metsera Inc. for $10 billion, Pfizer Inc. reported its first statistically significant top-line data of the acquired lead, ...

Astrazeneca plc is investing $15 billion in China through 2030 to expand R&D and manufacturing, marking one of the largest long-term investments by a multinational pharma company in the country. The U ...

An Anglo-American team of researchers has devised a new computational method for quantifying Epstein-Barr virus (EBV) ...

It’s not often that disclosure of a complete response letter (CRL) causes a company’s share price to rise, but that was case for Aquestive Therapeutics Inc., which saw its stock (NASDAQ:AQST) rise 39% ...

Google Deepmind is shedding light on the dark genome with its latest AI model, which is trained to decipher the 98% of DNA ...

With the PDUFA date fast approaching for Regenxbio Inc.’s gene therapy RGX-121, the U.S. FDA placed the drug on clinical hold ...

Tetrapharm (Tetra Pharm Technologies ApS) has announced promising preclinical data for TPC-026 for the chronic treatment and ...

Human respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) can cause severe and lethal bronchiolitis and ...

How much have AI applications learned, and how can one know their capabilities if they are being evaluated with an exam that ...

Zylox-Tonbridge Medical Technology Co. Ltd. plans to expand globally with M&As, company chairman and CEO Jonathon Zhong Zhao ...

Sensorion SA has announced a €60 million (US$72 million) financing, with a €20 million (US$24 million) strategic investment ...